Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia (Q41853897)
Jump to navigation
Jump to search
scientific article published on 22 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia |
scientific article published on 22 April 2009 |
Statements
1 reference
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia (English)
1 reference
Margaret Pinder
1 reference
W Ripley Ballou
1 reference
Opokua Ofori-Anyinam
1 reference
Marc Lievens
1 reference
Tom Doherty
1 reference
Amanda Leach
1 reference
Kent Kester
1 reference
Kurt Schaecher
1 reference
Joe Cohen
1 reference
1 reference
Identifiers
1 reference